NCT06664892View on ClinicalTrials.gov

Ultrahypofractionated Whole Breast Radiation Following Chemotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Breast Cancer
Interventions
RADIATION

Ultra-hypofractionated radiation

RT, delivered via external beam, 5.2 Gy per fraction for 5 fractions following BCS and neoadjuvant or adjuvant chemotherapy. Specific adjuvant/neoadjuvant therapies are at the discretion of the treating Medical Oncologist.

All Listed Sponsors
lead

MetroHealth Medical Center

OTHER